AT1 0.00% 2.1¢ atomo diagnostics limited

Thanks FinFree101Whilst the Access Bio & NG Biotech partnerships...

  1. 141 Posts.
    lightbulb Created with Sketch. 31

    Thanks FinFree101

    Whilst the Access Bio & NG Biotech partnerships from an OEM perspective have been disappointing,
    I'm really hopefully with the Lumos & FebriDx. The product is a massive game changer as the article
    pinpoints. Pending(hopeful) FDA approval, the fortunes of both Lumos & AT1 will improve dramatically.
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $13.42M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $53 2.5K

Buyers (Bids)

No. Vol. Price($)
5 284969 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 5165 2
View Market Depth
Last trade - 09.59am 02/09/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.